Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF MARCH 28, 2026 SAM #8888
SOLICITATION NOTICE

A -- Clinical Evaluation: Tropical Fever Testing & Support

Notice Date
3/26/2026 8:24:04 AM
 
Notice Type
Presolicitation
 
NAICS
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
 
Contracting Office
NAVSUP FLC SIGONELLA NAPLES OFFICE FPO AE 09622-0050 USA
 
ZIP Code
09622-0050
 
Solicitation Number
20260001558
 
Response Due
4/9/2026 7:00:00 AM
 
Archive Date
04/10/2026
 
Point of Contact
Tricia Folts
 
E-Mail Address
patricia.r.folts.civ@us.navy.mil
(patricia.r.folts.civ@us.navy.mil)
 
Small Business Set-Aside
NONE No Set aside used
 
Description
Pre-Solicitation Notice of Intent to Issue a Sole Source Contract Award Issuing Agency: Naval Supply Systems Command (NAVSUP) Fleet Logistics Center Sigonella � Naples (FLCSI-N) Requiring Agency: Navy Medical Research Unit Europe, Africa, Central (NAMRU EURAFCENT) Introduction: NAVSUP FLSCI-N, on behalf of NAMRU EURAFCENT, provides notification of its intent to issue a sole source, firm-fixed price purchase order to the University of Ghana Medical Center (UMGC). The contract is in support of a clinical evaluation of the Xpert� tropical fever test on the GeneXpert� Edge X system using venous and capillary whole blood specimens. The contract period of performance will be for a base period with a six-month option period. Nature of the Acquisition: This contract is for a scientific study title �258C2: Clinical Evaluation of the Xpert� tropical fever test on the GeneXpert� Edge X system using venous and capillary whole blood specimens�, which has been approved to be conducted at the University of Ghana Medical Centre (UMGC). The Xpert� Tropical Fever test is an automated, multiplex real-time PCR assay intended for the qualitative in vitro identification of nucleic acids from multiple fever-causing pathogens, including: Plasmodium species, Dengue virus, Zika virus, Chikungunya virus, and Leptospira species. Contractor Requirements: The contractor shall provide all necessary personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other non-personal services to perform sample collection and testing for protocol 258C2, as defined in the attached Performance Work Statement. The contractor is responsible for meeting all standards set forth in the contract terms, conditions, and standards issued by NAVSUP FLCSI-N. Additional Information: This acquisition is being conducted under the authority of Part 12 of the Revolutionary FAR Overhaul (RFO). This is a notice of intent and not a request for competitive proposals. The Government will consider all capability statements from responsible sources that believe they can meet the requirement. All capability statements must be received by 9 April 2026, 4:00 PM Central European Time (CET) to be considered. Responses shall be submitted via email to the Point of Contact (POC) identified in this notice. The statement must provide clear and convincing evidence of the interested party's ability to meet the Government's requirements as defined herein. The Government will not compensate interested parties for any costs related to the preparation or submission of a capability statement. Point of Contract: Tricia Folts, Contracting Officer | NAVSUP FLCSI-N | patricia.r.folts.civ@us.navy.mil
 
Web Link
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/cc23ad605a714fb79d040bd51f3f5d36/view)
 
Place of Performance
Address: GHA
Country: GHA
 
Record
SN07758255-F 20260328/260326230047 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2026, Loren Data Corp.